Steric configuration and polymorphic oxidation of lipophilic beta-adrenoceptor blocking agents: in vivo in vitro
- 1 February 1985
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 34 (3), 399-400
- https://doi.org/10.1016/0006-2952(85)90058-9
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Bufuralol metabolism in human liver: a sensitive probe for the debrisoquine‐type polymorphism of drug oxidationEuropean Journal of Clinical Investigation, 1984
- Contribution of the genetic status of oxidative metabolism to variability in the plasma concentrations of beta-adrenoceptor blocking agentsEuropean Journal of Clinical Pharmacology, 1983
- Defective metabolism of metoprolol in poor hydroxylators of debrisoquine.British Journal of Clinical Pharmacology, 1982
- Defective hydroxylation of bufuralol associated with side‐effects of the drug in poor metabolisers [letter]British Journal of Clinical Pharmacology, 1982
- Kinetics and metabolism of (+)-, (−)- and (±)-bufuralolEuropean Journal of Clinical Pharmacology, 1982
- The genetic controlof bufuralol metabolisminmanEuropean Journal of Drug Metabolism and Pharmacokinetics, 1982
- The metabolism of bufuralol: Urinary metabolite profiles in rat, dog and manEuropean Journal of Drug Metabolism and Pharmacokinetics, 1976